Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EU-TTG IGA AND EU-TTG IGG

K-Number: K102964 · 2011-03-07

Decision Date2011-03-07
Product CodeMVM
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

EU-TTG IGA AND EU-TTG IGG is the device name listed in this FDA 510(k) record. The listed applicant is Grifols USA, Inc.. It received FDA 510(k) clearance on 2011-03-07 under 510(k) number K102964. The device is classified under product code MVM. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EU-TTG IGA AND EU-TTG IGG?

EU-TTG IGA AND EU-TTG IGG is a medical device that received FDA 510(k) clearance on 2011-03-07. The listed applicant is Grifols USA, Inc.. The 510(k) number is K102964.

When did EU-TTG IGA AND EU-TTG IGG receive FDA 510(k) clearance?

EU-TTG IGA AND EU-TTG IGG received FDA 510(k) clearance on 2011-03-07, under 510(k) number K102964.

Who is the listed applicant for EU-TTG IGA AND EU-TTG IGG?

The FDA 510(k) record lists Grifols USA, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EU-TTG IGA AND EU-TTG IGG?

The FDA product code for EU-TTG IGA AND EU-TTG IGG is MVM.

Related Devices (Code: MVM)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑